TP53 and breast cancer: Thus, p53 was overexpressed in PS-BC cells (Figures S2C–E), and the functional experiments evidenced that upregulated p53 enhanced the inhibiting effects of paclitaxel on cell viability in the PS-BC cells (Figure 2J, K).